Silo Pharma (SILO) vs XORTX Therapeutics (XRTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
XORTX Therapeutics is the larger company by market cap ($3.2 million vs $2.8 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | SILO | XRTX |
|---|---|---|
| Share price | $1.37 | $1.75 |
| Market cap | $2.81M | $3.18M |
| 1-day change | -4.86% | +0.29% |
| Forward P/E | — | 2.18 |
| EPS (TTM) | $-4.26 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.44 | $7.05 |
| 52-week low | $1.30 | $1.59 |
| Distance from 52-week high | -86.88% | -75.18% |
| Average volume | 114.43K | 225.78K |
| Shares outstanding | 2.05M | 1.82M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
SILO vs XRTX FAQ
Which is bigger, Silo Pharma or XORTX Therapeutics?
XORTX Therapeutics (XRTX) is larger, with a market capitalization of $3.18M compared with $2.81M for Silo Pharma (SILO).
Are Silo Pharma and XORTX Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.